A Phase I Study of YY-20394 in Patients With Advanced Solid Tumors
Clinical trial NCT04049929 · UNKNOWN
Trial details
- NCT number
- NCT04049929
- Sponsor
- Shanghai YingLi Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2020-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.